Investing

The company announced the appointments of numerous individuals to its executive team and will use the funds to expand its partnerships and oncology platform.

The company will use the funds to prepare for commercialization in the U.S., enhance its platform and seek FDA clearance for its VERAFEYE platform.

Naomi Fried, founder and CEO of PharmStars, discusses the company's fifth cohort focused on solving challenges in therapeutic delivery and the 11 startups graduated from its accelerator program, including Cellular Vehicles and ZiO Health.  

Leaders in digital health foresee investors having a high bar for funding in 2024, looking toward companies with proven modalities and a clear pathway to profitability.

Also, BetterSpace in India has received pre-seed funding to develop mobile mental health games.

The California-based company will use the funds to expand its Whole Body Twin Technology, aimed at preventing and reversing metabolic disease.

The telehealth company is also betting on secondary care.

The gastrointestinal surgery-focused company will use the funds to advance its endoluminal robotics technology for minimally invasive procedures.

The funds will be used to develop a comprehensive AI imaging model powered by imaging data to improve diagnostic precisions and early detection of conditions.